Correlation Between Inhibikase Therapeutics and RenovoRx
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and RenovoRx, you can compare the effects of market volatilities on Inhibikase Therapeutics and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and RenovoRx.
Diversification Opportunities for Inhibikase Therapeutics and RenovoRx
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Inhibikase and RenovoRx is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and RenovoRx go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and RenovoRx
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 1.37 times more return on investment than RenovoRx. However, Inhibikase Therapeutics is 1.37 times more volatile than RenovoRx. It trades about 0.09 of its potential returns per unit of risk. RenovoRx is currently generating about 0.08 per unit of risk. If you would invest 134.00 in Inhibikase Therapeutics on November 2, 2024 and sell it today you would earn a total of 58.00 from holding Inhibikase Therapeutics or generate 43.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. RenovoRx
Performance |
| Timeline |
| Inhibikase Therapeutics |
| RenovoRx |
Inhibikase Therapeutics and RenovoRx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and RenovoRx
The main advantage of trading using opposite Inhibikase Therapeutics and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| RenovoRx vs. Adial Pharmaceuticals | RenovoRx vs. Pasithea Therapeutics Corp | RenovoRx vs. Quoin Pharmaceuticals Ltd | RenovoRx vs. Nutriband |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |